These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic. Depoortère R, Dargazanli G, Estenne-Bouhtou G, Coste A, Lanneau C, Desvignes C, Poncelet M, Heaulme M, Santucci V, Decobert M, Cudennec A, Voltz C, Boulay D, Terranova JP, Stemmelin J, Roger P, Marabout B, Sevrin M, Vigé X, Biton B, Steinberg R, Françon D, Alonso R, Avenet P, Oury-Donat F, Perrault G, Griebel G, George P, Soubrié P, Scatton B. Neuropsychopharmacology; 2005 Nov 15; 30(11):1963-85. PubMed ID: 15956994 [Abstract] [Full Text] [Related]
6. Commentary: genome-based CNS drug discovery: D-amino acid oxidase (DAAO) as a novel target for antipsychotic medications: progress and challenges. Williams M. Biochem Pharmacol; 2009 Dec 01; 78(11):1360-5. PubMed ID: 19591808 [Abstract] [Full Text] [Related]
8. Effects of sodium benzoate on pre-pulse inhibition deficits and hyperlocomotion in mice after administration of phencyclidine. Matsuura A, Fujita Y, Iyo M, Hashimoto K. Acta Neuropsychiatr; 2015 Jun 01; 27(3):159-67. PubMed ID: 25648314 [Abstract] [Full Text] [Related]
10. Mutant mice with reduced NMDA-NR1 glycine affinity or lack of D-amino acid oxidase function exhibit altered anxiety-like behaviors. Labrie V, Clapcote SJ, Roder JC. Pharmacol Biochem Behav; 2009 Feb 01; 91(4):610-20. PubMed ID: 18940194 [Abstract] [Full Text] [Related]
11. Modulation of NMDA receptor function by inhibition of D-amino acid oxidase in rodent brain. Strick CA, Li C, Scott L, Harvey B, Hajós M, Steyn SJ, Piotrowski MA, James LC, Downs JT, Rago B, Becker SL, El-Kattan A, Xu Y, Ganong AH, Tingley FD, Ramirez AD, Seymour PA, Guanowsky V, Majchrzak MJ, Fox CB, Schmidt CJ, Duplantier AJ. Neuropharmacology; 2011 Feb 01; 61(5-6):1001-15. PubMed ID: 21763704 [Abstract] [Full Text] [Related]
12. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions. Javitt DC. Int Rev Neurobiol; 2007 Feb 01; 78():69-108. PubMed ID: 17349858 [Abstract] [Full Text] [Related]
13. Modulating NMDA Receptor Function with D-Amino Acid Oxidase Inhibitors: Understanding Functional Activity in PCP-Treated Mouse Model. Sershen H, Hashim A, Dunlop DS, Suckow RF, Cooper TB, Javitt DC. Neurochem Res; 2016 Feb 01; 41(1-2):398-408. PubMed ID: 26857796 [Abstract] [Full Text] [Related]
17. Stereoselective antagonism by enantiomers of alanine and serine of phencyclidine-induced hyperactivity, stereotypy and ataxia in the rat. Tanii Y, Nishikawa T, Hashimoto A, Takahashi K. J Pharmacol Exp Ther; 1994 Jun 01; 269(3):1040-8. PubMed ID: 8014848 [Abstract] [Full Text] [Related]
18. Phosphodiesterase 10A inhibitor activity in preclinical models of the positive, cognitive, and negative symptoms of schizophrenia. Grauer SM, Pulito VL, Navarra RL, Kelly MP, Kelley C, Graf R, Langen B, Logue S, Brennan J, Jiang L, Charych E, Egerland U, Liu F, Marquis KL, Malamas M, Hage T, Comery TA, Brandon NJ. J Pharmacol Exp Ther; 2009 Nov 01; 331(2):574-90. PubMed ID: 19661377 [Abstract] [Full Text] [Related]
19. The effects of glycine transporter I inhibitor, N-methylglycine (sarcosine), on ketamine-induced alterations in sensorimotor gating and regional brain c-Fos expression in rats. Yang SY, Hong CJ, Huang YH, Tsai SJ. Neurosci Lett; 2010 Jan 18; 469(1):127-30. PubMed ID: 19944746 [Abstract] [Full Text] [Related]
20. Contribution of endogenous glycine and d-serine to excitotoxic and ischemic cell death in rat cerebrocortical slice cultures. Katsuki H, Watanabe Y, Fujimoto S, Kume T, Akaike A. Life Sci; 2007 Aug 09; 81(9):740-9. PubMed ID: 17698151 [Abstract] [Full Text] [Related] Page: [Next] [New Search]